{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:59:05Z","timestamp":1787162345214,"version":"build-2736575974"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.jinf.2012.12.004","type":"journal-article","created":{"date-parts":[[2013,1,3]],"date-time":"2013-01-03T02:34:15Z","timestamp":1357180455000},"page":"263-270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["Intravenous ceftriaxone, followed by 12 or three months of oral treatment with trimethoprim-sulfamethoxazole in Whipple's disease"],"prefix":"10.1016","volume":"66","author":[{"given":"Gerhard E.","family":"Feurle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Moos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Bl\u00e4ker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Loddenkemper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Moter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Stroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Marth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2012.12.004_bib1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00004836-199106000-00010","article-title":"Short-term antibiotic treatment in Whipple's disease","volume":"13","author":"Bai","year":"1991","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jinf.2012.12.004_bib2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1056\/NEJMra062477","article-title":"Whipple's disease","volume":"356","author":"Fenollar","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2012.12.004_bib3","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nrgastro.2010.46","article-title":"How should classic Whipple's disease be managed?","volume":"7","author":"Fenollar","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.jinf.2012.12.004_bib4","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/jac\/dkr032","article-title":"Evidence of lifetime susceptibility to Tropheryma whipplei in patients with Whipple's disease","volume":"66","author":"Lagier","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.jinf.2012.12.004_bib5","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1053\/j.gastro.2009.10.041","article-title":"Efficacy of ceftriaxone or meropenem as initial therapies in Whipple's disease","volume":"138","author":"Feurle","year":"2010","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.jinf.2012.12.004_bib6","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/BF00198437","article-title":"Histology of intestinal Whipple's disease revisited. A study of 48 patients","volume":"429","author":"von Herbay","year":"1996","journal-title":"Virchows Arch"},{"issue":"6","key":"10.1016\/j.jinf.2012.12.004_bib7","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1053\/gast.1996.v110.pm8964398","article-title":"Diagnostic application of a polymerase chain reaction assay for the Whipple's disease bacterium to intestinal biopsies","volume":"110","author":"von Herbay","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jinf.2012.12.004_bib8","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0046-8177(03)00126-6","article-title":"Whipple's disease: immunospecific and quantitative immunohistochemical study of intestinal biopsy specimens","volume":"34","author":"Lepidi","year":"2003","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1016\/j.jinf.2012.12.004_bib9","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/jac\/dks008","article-title":"The combination of minocycline and chloroquine as therapeutic option in cerebrospinal Whipple\u2019s disease, refractory to ceftriaxone, meropenem, and co-trimoxazole","volume":"67","author":"Feurle","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2012.12.004_bib10","doi-asserted-by":"crossref","first-page":"710","DOI":"10.7326\/0003-4819-153-11-201012070-00004","article-title":"The immune reconstitution inflammatory syndrome in Whipple disease","volume":"153","author":"Feurle","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jinf.2012.12.004_bib11","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/jac\/dkh524","article-title":"Molecular evaluation of antibiotic susceptibility of Tropheryma whipplei in axenic medium","volume":"55","author":"Boulos","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2012.12.004_bib12","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1016\/S0002-9270(00)01137-0","article-title":"Whipple\u2019s disease: acquired resistance to trimethoprim-sulfamethoxazole","volume":"95","author":"Levy","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jinf.2012.12.004_bib13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1086\/588706","article-title":"Acquired resistance to trimethoprim-sulfamethoxazole during Whipple disease and expression of the causative target gene","volume":"198","author":"Bakkali","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2012.12.004_bib14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijantimicag.2009.02.014","article-title":"Resistance to trimethoprim\/sulfamethoxazole and Tropheryma whipplei","volume":"34","author":"Fenollar","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jinf.2012.12.004_bib15","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1086\/528693","article-title":"Prevalence of asymptomatic Tropheryma whipplei carriage among humans and nonhuman primates","volume":"197","author":"Fenollar","year":"2008","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2012.12.004_bib16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1473-3099(08)70042-2","article-title":"Whipple's disease: new aspects of pathogenesis and treatment","volume":"8","author":"Schneider","year":"2008","journal-title":"Lancet Infect Dis"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445312003854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445312003854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:17:49Z","timestamp":1759007869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445312003854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0163445312003854"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2012.12.004","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous ceftriaxone, followed by 12 or three months of oral treatment with trimethoprim-sulfamethoxazole in Whipple's disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2012.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}